Operating Cash Flow
Idexx Laboratories Operating Cash Flow decreased by 25.2% to $266.25M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.9%, from $237.96M to $266.25M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 11.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Consistently high operating cash flow indicates a healthy, self-sustaining business capable of funding its own growth and returning capital to shareholders.
Detailed definition
Net cash from operating activities measures the total amount of cash generated by a company's core business operations....
Peer comparison
Investors often compare this to capital expenditures to calculate Free Cash Flow, a primary valuation metric for mature tech giants.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $233.96M | $187.21M | $209.96M | $114.71M | $65.85M | $189.00M | $173.43M | $183.91M | $200.31M | $272.43M | $249.85M | $198.59M | $248.31M | $220.08M | $262.03M | $237.96M | $185.74M | $402.34M | $355.76M | $266.25M |
| QoQ Change | — | -20.0% | +12.2% | -45.4% | -42.6% | +187.0% | -8.2% | +6.0% | +8.9% | +36.0% | -8.3% | -20.5% | +25.0% | -11.4% | +19.1% | -9.2% | -21.9% | +116.6% | -11.6% | -25.2% |
| YoY Change | — | — | — | — | -71.9% | +1.0% | -17.4% | +60.3% | +204.2% | +44.1% | +44.1% | +8.0% | +24.0% | -19.2% | +4.9% | +19.8% | -25.2% | +82.8% | +35.8% | +11.9% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's operating cash flow?
- Idexx Laboratories (IDXX) reported operating cash flow of $266.25M in Q1 2026.
- How has Idexx Laboratories's operating cash flow changed year-over-year?
- Idexx Laboratories's operating cash flow increased by 11.9% year-over-year, from $237.96M to $266.25M.
- What is the long-term trend for Idexx Laboratories's operating cash flow?
- Over 4 years (2021 to 2025), Idexx Laboratories's operating cash flow has grown at a 11.8% compound annual growth rate (CAGR), from $755.55M to $1.18B.
- What does operating cash flow mean?
- The actual amount of cash a company brings in from its day-to-day business activities.